European Advisory Panel Backs Conditional Approval For Madrigal's Fatty Liver Disease Drug

Why is Kroger closing 60 stores? How will Tesla’s robotaxi launch impact its stock? What caused Circle’s stock to surge recently? Why is the Fed considering rate cuts this fall? How is the Israel-Iran conflict affecting oil prices? Why did Japan cancel US defense spending talks? What’s behind the rise in consumer grocery spending?

European Advisory Panel Backs Conditional Approval For Madrigal's Fatty Liver Disease Drug

benzinga.com/news/health-care/25/06/46035838/european-advisory-panel-backs-conditional-approval-for-madrigals-fatty-liver-disease-drug

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted on Friday a positive opinion recommending approval for Madrigal Pharmaceuticals, Inc.’s (NASDAQ:MDGL) resmetirom (Rezdiffra) for adults with noncirrhotic MASH with moderate to…

This story appeared on benzinga.com, 2025-06-20 18:56:30.